Results 121 to 130 of about 143,361 (253)

Dry Cleaning and Post‐Cleaning Strategies in Food Processing Facilities: A Scoping Review

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 4, July 2026.
ABSTRACT Effective dry cleaning and post‐cleaning treatments are essential for maintaining food safety in dry‐food processing environments where water use must be minimized. This scoping review mapped and synthesized empirical research on minimal‐water cleaning methods applied to industrial surfaces, focusing on their efficacy against microbial and ...
Zahra Shahbazi, Curtis L. Weller, Prashant Dahal, Byron D. Chaves   +3 more
wiley   +1 more source

Intravesical therapy for recurrent urinary tract infection: a systematic review and meta‐analysis

BJU International, Volume 138, Issue 1, Page 33-44, July 2026.
Objective To undertake a systematic review and meta‐analysis to evaluate the efficacy, safety, and clinical applicability of intravesical instillations for preventing recurrent urinary tract infections (rUTIs). Methods PubMed/MEDLINE, Embase, Cochrane CENTRAL, Scopus, and Web of Science were searched from January 2000 to April 2025 for randomised and ...
Matthew Kwon, Asaad Ahmad, Natalie Lott, Alison Blatt   +3 more
wiley   +1 more source

Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection

Microorganisms
Clostridioides difficile infection (CDI) is the leading cause of nosocomial antibiotic-associated diarrhea, and colitis, with increasing incidence and healthcare costs. Its pathogenesis is primarily driven by toxins produced by the bacterium C. difficile,
Evdokia Pourliotopoulou, T. Karampatakis, Melania Kachrimanidou   +2 more
semanticscholar   +1 more source

Validation of an Automated Fluorescence‐ and Image‐Based Viable Cell Counting Method for Fecal Microbiota Transplantation Drug Products

Biotechnology Journal, Volume 21, Issue 6, June 2026.
Graphical Abstract and Lay Summary This study presents the first systematic development and analytical validation of an automated fluorescence‐ and image‐based viable‐cell counting method for fecal microbiota transplantation (FMT) drug products in accordance with ICH Q2(R2).
Timon Lang, Fedja Farowski, Jozef Al‐Gousous, Peter Langguth, Maria J. G. T. Vehreschild   +4 more
wiley   +1 more source

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile

Frontiers in Microbiology, 2019
Clostridioides difficile infection (CDI) is increasing morbidity and mortality rates globally. Fecal microbiota transplantation (FMT), an effective therapy for eliminating Clostridioides difficile (C.
Xianping Li, Xianping Li, Qiongfang Chu, Qiongfang Chu, Qiongfang Chu, Yuanming Huang, Yuanming Huang, Yuchun Xiao, Yuchun Xiao, Liqiong Song, Liqiong Song, Siyi Zhu, Siyi Zhu, Ying Kang, Ying Kang, Shan Lu, Shan Lu, Jianguo Xu, Jianguo Xu, Zhihong Ren, Zhihong Ren   +20 more
doaj   +1 more source

SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection

Drugs
SER-109 (VOWST™; fecal microbiota spores, live-brpk) is a live biotherapeutic product indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in patients 18 years of age and older following standard of care (SOC) antibacterial ...
Hannah A. Blair
semanticscholar   +1 more source

Lansoprazole‐Induced Microscopic Colitis Mimicking Anticancer Drug‐Related Diarrhea During Lenvatinib and Pembrolizumab Combination Therapy: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Persistent diarrhea during anticancer therapy may not be attributable to anticancer agents. Our patient presented with diarrhea during lenvatinib–pembrolizumab therapy, likely caused by lansoprazole‐induced microscopic colitis. Even when symptoms closely resemble anticancer drug or immune‐related colitis, drug‐induced colitis due to ...
Shinichi Maruyama, Takuro Hirano, Kazuhiro Fuchinoue, Yoshikiyo Akasaka, Takanori Yoshida, Hiroshi Kanno, Masaru Kato   +6 more
wiley   +1 more source

Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.

Clinical Infectious Diseases
BACKGROUND Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of
Michael J. Ray, Luke C. Strnad, Kendall J. Tucker, Jon P. Furuno, Eric Lofgren, Caitlin M. McCracken, Hiromichi S. Park, Jeffrey S. Gerber, Jessina C. McGregor   +8 more
semanticscholar   +1 more source

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1514-1521, June 2026.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld, Geetha S. Iyer, Suna C. Seo, Andrew Giffin, Andrew L. Simon, Sheryl A. Kluberg, Emma R. Hoffman, Jamal T. Jones, Sarah K. Dutcher, Joyce A. Korvick   +9 more
wiley   +1 more source

The global burden and trend of Clostridioides difficile and its association with world antibiotic consumption, 1990–2019

Journal of Global Health
Background To estimate the global trends and disease burden of Clostridioides difficile infection (CDI) and its correlation with worldwide antibiotic consumption.
Yonghao Chen, Xiaoxi Xie, Qintao Ge, Xiaogang He, Zhiyuan Sun, Yanni Li, Yaoyu Guo, Chong Geng, Xiao Li, Chunhui Wang   +9 more
semanticscholar   +1 more source